Tongxiang, China

Jianbo Yu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Scinopharm Taiwan, Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianbo Yu. Retrieved from https://idiyas.com/inventor/jianbo-yu-k6mdozif

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jianbo Yu: Innovating in Pharmaceutical Synthesis

Introduction: Jianbo Yu is a distinguished inventor located in Tongxiang, China, known for his contributions to pharmaceutical chemistry. With a focus on innovative synthesis methods, he has made significant strides in the field, exemplified by his patent related to decitabine.

Latest Patents: Jianbo Yu holds one notable patent: "Synthesis of decitabine." This patent details a method for producing a β-enriched protected decitabine, showcasing his expertise in pharmaceutical synthesis and formulation.

Career Highlights: Jianbo Yu is currently associated with Scinopharm Taiwan, Ltd., a leading company in the pharmaceutical industry. His work with Scinopharm has positioned him as a valuable contributor to the development of cutting-edge methods in drug synthesis, helping advance the field of pharmaceutical sciences.

Collaborations: Throughout his career, Jianbo Yu has collaborated with talented professionals such as Julian Paul Henschke and Xiaoheng Zhang. These collaborative efforts have further enriched his research and have led to innovative solutions in the realm of pharmaceutical research.

Conclusion: Jianbo Yu exemplifies the spirit of innovation within the pharmaceutical industry. His contributions, highlighted by his patent and collaborations, not only advance scientific understanding but also pave the way for new advancements in drug synthesis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…